This is a non-core endpoint: only basic statistics are computed.
See these related core endpoints for full statistics:
Malignant neoplasm of floor of mouth, excluding all cancers (controls excluding all cancers)
C3_FLOOROFMOUTH_EXALLC
No definition available.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
3 out of 7 registries used, show all original rules. |
297 |
4. Check minimum number of eventsNone |
297 |
5. Include endpointsNone |
297 |
6. Filter based on genotype QC (FinnGen only) |
297 |
Control definitions (FinnGen only)
- Control exclude
- C3_CANCER, C3_CANCER_WIDE_EXALLC
Extra metadata
- First used in FinnGen datafreeze
- DF12
Similar endpoints
↥List of similar endpoints to
Malignant neoplasm of floor of mouth, excluding all cancers (controls excluding all cancers)
based on the number of shared cases.
Similar with more cases:
- Malignant neoplasm of oral cavity, excluding all cancers (controls excluding all cancers)
- Malignant neoplasm of head and neck, excluding all cancers (controls excluding all cancers)
- Malignant neoplasm, excluding all cancers (controls excluding all cancers)
- Malignant neoplasm, wide definition for exclusion
- Malignant neoplasm, wide definition for exclusion, excluding all cancers (controls excluding all cancers)
Similar with less cases:
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 297 | 106 | 191 |
| Unadjusted period prevalence (%) | 0.07 | 0.04 | 0.08 |
| Median age at first event (years) | 63.00 | 62.21 | 63.44 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 154
- Matched controls
- 1538
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
8070/3-C04.9
ICD-O-3
Squamous cell carcinoma, NOS, of floor of mouth, NOS
+∞
117.1
97
*
C04.0
ICD-10 Finland
Malignant neoplasm: Anterior floor of mouth
+∞
100.2
85
*
EJB30
NOMESCO Finland
Excision of lesion of floor of mouth
+∞
86.9
75
*
EJA10
NOMESCO Finland
Biopsy of tongue or floor of mouth
143.5
84.8
85
13
130
Kela drug reimbursment
Malignant tumour
+∞
75.3
66
*
GBB00
NOMESCO Finland
Tracheostomy
119.9
66.0
68
10
504
Kela drug reimbursment
Conditions requiring daily forced enteral nutrition
236.7
60.9
59
*
JDB10
NOMESCO Finland
Percutaneous gastrostomy
155.1
51.6
52
5
WF003
NOMESCO Finland
Adjuvant radiotherapy
+∞
49.7
45
*
WZC00
NOMESCO Finland
Planning of intervention or health care consultation
15.0
49.5
109
214
C04.1
ICD-10 Finland
Malignant neoplasm: Lateral floor of mouth
+∞
48.5
44
*
PJD71
NOMESCO Finland
Extended sparing excision of cervical lymph nodes
+∞
47.4
43
*
PJD81
NOMESCO Finland
Excision of lymph nodes from upper part of neck
492.8
40.0
38
*
ZZQ00
NOMESCO Finland
Free microvascular graft of skin
+∞
38.1
35
*
K08.1
ICD-10 Finland
Loss of teeth due to accident, extraction or local periodontal disease
12.9
36.1
72
98
C04.9
ICD-10 Finland
Malignant neoplasm: Floor of mouth, unspecified
+∞
34.7
32
*
EP1AE
NOMESCO Finland
Neck ultrasound examination
24.1
34.5
50
30
EDB00
NOMESCO Finland
Partial excision of mandible
420.0
34.3
33
*
XX3DW
NOMESCO Finland
Time consuming IT work
25.7
32.6
46
25
EN1BD
NOMESCO Finland
Very extensive CT examination of mouth and soft tissues of neck
86.3
31.4
34
5
SAA03
NOMESCO Finland
Extended examination of mouth
7.5
29.6
105
342
C04.8
ICD-10 Finland
Malignant neoplasm: Overlapping lesion of floor of mouth
+∞
29.1
27
*
SBB10
NOMESCO Finland
Teeth copy
21.6
28.9
43
27
WZC05
NOMESCO Finland
Specialty-specific consultation based on referral by dentist or doctor
18.2
27.7
44
33
A07AA02
ATC
nystatin; oral
17.1
26.5
43
34
WZC20
NOMESCO Finland
Multidisciplinary treatment meeting
70.7
26.0
29
5
C03.1
ICD-10 Finland
Malignant neoplasm: Lower gum
+∞
25.7
24
*
A03FA01
ATC
metoclopramide; systemic, rectal
10.2
25.2
54
77
WB103
NOMESCO Finland
Simple adjuvant cytostatic therapy
+∞
24.6
23
*
EJB60
NOMESCO Finland
Partial excision of floor of mouth
+∞
24.6
23
*
ZX012
NOMESCO Finland
Radiotherapy with large shaped fields - isocentric therapy
281.9
24.4
24
*
EP1CG
NOMESCO Finland
Extensive MRI examination of soft tissue of neck with high intesity magnet
56.5
24.3
28
6
ZX090
NOMESCO Finland
Other technic of radiotherapy
+∞
23.5
22
*
N02AA05
ATC
oxycodone; systemic
9.1
23.4
54
86
EN1AD
NOMESCO Finland
CT examination of mouth and soft tissues of neck
141.0
23.3
24
*
EBA15
NOMESCO Finland
Extraction of large number of teeth
18.5
22.5
35
24
WZC10
NOMESCO Finland
Extensive specialist consultion with written report
19.5
22.3
34
22
8070/3-C04.0
ICD-O-3
Squamous cell carcinoma, NOS, of anterior floor of mouth
+∞
20.2
19
*
K13.79
ICD-10 Finland
Change in the oral mucosa UNS
24.1
19.9
28
14
EBB10
NOMESCO Finland
Insertion of dental implant
53.6
19.8
23
5
H02AB02
ATC
dexamethasone; systemic
40.2
19.6
24
7
WF002
NOMESCO Finland
Radical radiotherapy
+∞
19.1
18
*
C02.11
ICD-10 Finland
Malignant neoplasm of border of tongue
+∞
19.1
18
*
ZZA00
NOMESCO Finland
Split skin graft
35.1
19.0
24
8
EP1DG
NOMESCO Finland
Very extensive examination of soft tissue of neck with high intesity magnet
215.0
19.0
19
*
WX408
NOMESCO Finland
General anesthesy, balanced
5.4
18.6
68
195
TPH20
NOMESCO Finland
Insertion of central venous catheter through subclavian or brachiocephalic vein
26.8
18.4
25
11
SBB00
NOMESCO Finland
Fotograf of mouth and teeth
15.9
18.4
30
23
K08.2
ICD-10 Finland
Atrophy of edentulous alveolar ridge
107.6
18.0
19
*
ECA20
NOMESCO Finland
Biopsy of gingiva
107.6
18.0
19
*
SPA00
NOMESCO Finland
Changing form of teeth in prepation for prothetic work
14.0
17.5
30
26
EBB15
NOMESCO Finland
Insertion of dental implant abutment
71.6
17.2
19
*
YA1BD
NOMESCO Finland
Extensive CT examination of head and neck for dose design of radiotherapy
+∞
17.0
16
*
A04AA02
ATC
granisetron; systemic, transdermal
+∞
17.0
16
*
F10.1
ICD-10 Finland
Mental and behavioural disorders due to use of alcohol, Harmful use
8.7
16.5
37
54
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
5.3
16.5
59
162
TJD20
NOMESCO Finland
Change of gastrostomy tube
177.1
15.8
16
*
EBA10
NOMESCO Finland
Surgical removal of tooth
7.6
15.8
39
66
N02AB03
ATC
fentanyl; nasal, sublingual, transdermal
17.5
15.5
24
16
Z51.5
ICD-10 Finland
Palliative care
17.8
15.0
23
15
GDA98
NOMESCO Finland
Other bronchoscopic incision, excision of lesion or repair of lung
88.7
14.9
16
*
PJA12
NOMESCO Finland
Sentinel node biopsy
+∞
14.8
14
*
JN4KR
NOMESCO Finland
Whole body very extensive metabolic PET with CT
+∞
14.8
14
*
SPA20
NOMESCO Finland
Selection and insertion of implantdistans
+∞
14.8
14
*
YA1CD
NOMESCO Finland
Very extensive CT examination of head and neck for dose design of radiotherapy
+∞
13.7
13
*
EBB11
NOMESCO Finland
Insertion of additional dental implant in one session
+∞
13.7
13
*
SXC03
NOMESCO Finland
Other oral or dental procedure
28.8
13.7
18
7
WD125
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
152.8
13.7
14
*
AA3AI
NOMESCO Finland
Cone beam CT of facial bones
152.8
13.7
14
*
K13.78
ICD-10 Finland
Other change in the oral mucosa
17.1
13.5
21
14
UDQ12
NOMESCO Finland
Flexible laryngoscopy
10.5
13.4
26
29
TJD00
NOMESCO Finland
Insertion of nasogastric or naso-gastroduodenal tube
55.0
13.1
15
*
SCA02
NOMESCO Finland
Analysis and advice of nutrition with regard to dentistry
7.3
13.0
32
53
K13.29
ICD-10 Finland
Indefinite leukoplakia
35.4
12.8
16
5
EB1BI
NOMESCO Finland
Cone beam imaging of teeth and jaws (1–2 quarters)
35.4
12.8
16
5
ZX070
NOMESCO Finland
Intensity modified radiotherapy
+∞
12.7
12
*
YA1AD
NOMESCO Finland
CT examination of head and neck for dose design of radiotherapy
+∞
12.7
12
*
8070/3-C04.1
ICD-O-3
Squamous cell carcinoma, NOS, of lateral floor of mouth
+∞
12.7
12
*
K10.26
ICD-10 Finland
Periostitis of jaw (acute)(chronic)(suppurative)
+∞
12.7
12
*
C77.0
ICD-10 Finland
Secondary and unspecified malignant neoplasm: Lymph nodes of head, face and neck
+∞
12.7
12
*
SXC05
NOMESCO Finland
Other oral or dental procedure
10.1
12.6
25
29
EB1HA
NOMESCO Finland
Panorama tomography of teeth and jaws or similar X-ray examination
3.5
12.2
86
409
SPF00
NOMESCO Finland
Repatation of teeth prosthesis
16.5
12.2
19
13
PJD41
NOMESCO Finland
Excision of cervical lymph nodes
50.9
12.1
14
*
A04AA01
ATC
ondansetron; systemic, rectal
16.8
11.6
18
12
WF049
NOMESCO Finland
Radiotherapy of metastasis
+∞
11.6
11
*
YA1VG
NOMESCO Finland
MRI examination of head and neck with high intesity magnet for dose design of radiotherapy
+∞
11.6
11
*
C61
ICD-10 Finland
Malignant neoplasm of prostate
+∞
11.6
11
*
EJC99
NOMESCO Finland
Other reconstructive operations on tongue and floor of mouth
+∞
11.6
11
*
WX402
NOMESCO Finland
General anaesthesia
4.9
11.5
40
102
SAA04
NOMESCO Finland
Special inverstigation of mouth
7.8
11.3
26
39
SXB00
NOMESCO Finland
Removeal of sutres from oral mucosa
7.0
11.3
28
47
GD1AD
NOMESCO Finland
Thorax CT examination
10.4
10.9
21
23
EB1CI
NOMESCO Finland
Cone beam imaging of teeth and jaws (3-4 quarters)
117.6
10.6
11
*
SPD05
NOMESCO Finland
Demanding fitting of total teeth prosthesis
117.6
10.6
11
*
EJW99
NOMESCO Finland
Other operation on tongue or floor of mouth
117.6
10.6
11
*
PJD51
NOMESCO Finland
Block dissection of cervical lymph nodes
+∞
10.5
10
*
JCW98
NOMESCO Finland
Other transluminal endoscopic procedure on oesophagus
+∞
10.5
10
*
WF004
NOMESCO Finland
Palliative radiotherapy
+∞
10.5
10
*
8140/3-C61.9
ICD-O-3
Adenocarcinoma, NOS, of prostate gland
+∞
10.5
10
*
A04AD12
ATC
aprepitant; systemic
+∞
10.5
10
*
QAB05
NOMESCO Finland
Revision of wound of skin of head or neck
+∞
10.5
10
*
C03.0
ICD-10 Finland
Malignant neoplasm: Upper gum
+∞
10.5
10
*
UJC01
NOMESCO Finland
Scopy of lower throat
35.2
10.5
13
*
EB1AI
NOMESCO Finland
Cone beam imaging of teeth and jaws (one quarter)
25.4
10.4
14
6
SPF10
NOMESCO Finland
Demanding repatation of teeth prosthesis
14.5
10.4
17
13
R4190
NOMESCO Finland
Nutritional therapy
13.5
10.1
17
14
F10.29
ICD-10 Finland
Addiction caused by alcohol UNS
10.7
10.1
19
20
EKA10
NOMESCO Finland
Biopsy of cheek
13.6
9.6
16
13
JN5DR
NOMESCO Finland
PET-CT of upper body metabolism
32.3
9.5
12
*
EB1WA
NOMESCO Finland
NA
106.2
9.5
10
*
WZC30
NOMESCO Finland
Teaching
5.6
9.5
28
59
C79.8
ICD-10 Finland
Secondary malignant neoplasm of other specified sites
+∞
9.5
9
*
K10.20
ICD-10 Finland
Osteomyelitis (neonatal) of jaw (acute)(chronic)(suppurative)
+∞
9.5
9
*
GD6AD
NOMESCO Finland
CT of chest and neck
+∞
9.5
9
*
JN4JR
NOMESCO Finland
Whole body extensive metabolic PET with CT
+∞
9.5
9
*
ZZQ20
NOMESCO Finland
Free microvascular graft of skin, muscle and bone
+∞
9.5
9
*
EJB99
NOMESCO Finland
Other excision on tongue and floor of mouth
+∞
9.5
9
*
OAB73
NOMESCO Finland
Prevention and treatment of malnutrition
+∞
9.5
9
*
R13
ICD-10 Finland
Dysphagia
6.1
9.3
25
47
WX110
NOMESCO Finland
Local anesthesy
3.1
9.2
114
743
SBA00
NOMESCO Finland
Microbiological examinations
13.7
9.1
15
12
EBA00
NOMESCO Finland
Extraction of tooth
3.0
8.9
66
305
GD1BD
NOMESCO Finland
Thorax extensive CT-examination
7.8
8.9
20
29
ZZR00
NOMESCO Finland
Flap of skin
53.0
8.8
10
*
SXC02
NOMESCO Finland
Other oral or dental procedure, restricted
12.6
8.8
15
13
SXA10
NOMESCO Finland
Epithel biopsy of mouth
17.6
8.7
13
8
SPF20
NOMESCO Finland
Temporary soling for filling
29.4
8.6
11
*
TEW99
NOMESCO Finland
Other minor procedure in surgery of teeth, jaws, mouth and pharynx
9.4
8.6
17
20
J02AC01
ATC
fluconazole; systemic
3.0
8.5
64
298
601
Kela drug reimbursment
Severe malabsorption of nutrients, mainly fats
95.0
8.5
9
*
EJB10
NOMESCO Finland
Excision of lesion of apex or body of tongue
95.0
8.5
9
*
YX9BD
NOMESCO Finland
Other extensive CT eamination for dose design of radiotherapy
+∞
8.4
8
*
YX9AD
NOMESCO Finland
Other CT eamination for dose design of radiotherapy
+∞
8.4
8
*
EDB20
NOMESCO Finland
Hemimandibulectomy
+∞
8.4
8
*
A04AA55
ATC
palonosetron, combinations; systemic
+∞
8.4
8
*
C01
ICD-10 Finland
Malignant neoplasm of base of tongue
+∞
8.4
8
*
K13.28
ICD-10 Finland
Other leukoplakia or disorder of epithelium of the palate or tongue
+∞
8.4
8
*
SPF30
NOMESCO Finland
Soling for prothesis
12.7
8.3
14
12
ECB20
NOMESCO Finland
Oral alveoplasty
23.5
8.1
11
5
N05AA02
ATC
levomepromazine; systemic
8.5
8.1
17
22
GD1AA
NOMESCO Finland
Thorax X-ray examination
2.7
8.1
84
475
N07BA03
ATC
varenicline; oral
5.8
7.9
22
43
QAE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin in head or neck
8.8
7.8
16
20
D83
ICPC
Mouth/tongue/lip disease
47.4
7.8
9
*
K12.2
ICD-10 Finland
Cellulitis and abscess of mouth
47.4
7.8
9
*
SPD00
NOMESCO Finland
Fitting and preparation of total teeth prosthesis
19.6
7.7
11
6
SPD01
NOMESCO Finland
Mucosa-supported complete denture
26.5
7.7
10
*
D10.2
ICD-10 Finland
Benign neoplasm: Floor of mouth
83.9
7.5
8
*
EDW99
NOMESCO Finland
Other operation on mandible
83.9
7.5
8
*
SHA03
NOMESCO Finland
Correction of physiology of bite - demanding therapy visit
10.1
7.5
14
15
C06.9
ICD-10 Finland
Malignant neoplasm: Mouth, unspecified
+∞
7.3
7
*
L03AA13
ATC
pegfilgrastim; parenteral
+∞
7.3
7
*
EDC42
NOMESCO Finland
Mandibular repair with implant
+∞
7.3
7
*
EJB40
NOMESCO Finland
Hemiglossectomy
+∞
7.3
7
*
D37.08
ICD-10 Finland
Tumor of uncertain or unknown nature in other part of lip, oral cavity and pharynx
31.6
7.2
9
*
SHA02
NOMESCO Finland
Correction of physiology of bite - basic therapy visit
7.6
7.2
16
23
SAA02
NOMESCO Finland
Basic examination of mouth
2.5
7.2
95
598
WX404
NOMESCO Finland
Intravenous generell anesthesy
3.3
7.1
38
138
F10.39
ICD-10 Finland
Withdrawal symptoms caused by alcohol UNS
14.7
7.0
11
8
WX872
NOMESCO Finland
Intensive care
5.1
6.9
21
46
JN4BD
NOMESCO Finland
Extensive body CT
5.7
6.9
19
37
D20
ICPC
Mouth/tongue/lip symptom/complaint
7.0
6.8
16
25
Z71.3
ICD-10 Finland
Dietary counselling and surveillance
6.4
6.8
17
29
WX707
NOMESCO Finland
Fiberoscopic intubation
41.9
6.8
8
*
R4130
NOMESCO Finland
Speech therapy
9.3
6.7
13
15
N02AX02
ATC
tramadol; systemic, rectal
2.4
6.5
79
467
TPH30
NOMESCO Finland
Insertion of central venous catheter through periferal vein
15.1
6.5
10
7
PJD91
NOMESCO Finland
Excision of lymph nodes in neck, 1 to 2 areas in total
72.7
6.5
7
*
JDB00
NOMESCO Finland
Gastrostomy
72.7
6.5
7
*
SPA10
NOMESCO Finland
Setting attachments on tooth or implanted bracket or imblant based structures
72.7
6.5
7
*
QAB10
NOMESCO Finland
Major dressing of wound of skin of head or neck
72.7
6.5
7
*
EHA10
NOMESCO Finland
Biopsy of palate
72.7
6.5
7
*
F10.20
ICD-10 Finland
Alcohol dependence currently independent
9.9
6.4
12
13
3039X
ICD-9 Finland
Alcohol dependence syndrome, Other and unspecified alcohol dependence
11.7
6.4
11
10
L03AA02
ATC
filgrastim; parenteral
27.9
6.3
8
*
SBB20
NOMESCO Finland
Tooth X-ray examination in conjunction with visit to dentist
27.9
6.3
8
*
ZZQ10
NOMESCO Finland
Free microvascular graft of skin and muscle
+∞
6.3
6
*
C06.0
ICD-10 Finland
Malignant neoplasm: Cheek mucosa
+∞
6.3
6
*
SCB02
NOMESCO Finland
Training for mouth care at home
+∞
6.3
6
*
Z43.1
ICD-10 Finland
Attention to gastrostomy
+∞
6.3
6
*
EB1JA
NOMESCO Finland
Double panorama tomography of teeth and jaws or similar X-ray examination
+∞
6.3
6
*
EDA10
NOMESCO Finland
Biopsy of mandible
+∞
6.3
6
*
C78.0
ICD-10 Finland
Secondary malignant neoplasm of lung
+∞
6.3
6
*
K05.31
ICD-10 Finland
Periodontitis pronounced
3.4
6.3
30
101
SCA03
NOMESCO Finland
Preventive oral health care, extensive
8.2
6.3
13
17
R2130
NOMESCO Finland
Counselling and guidance which enhance independent living
4.2
6.2
23
62
R22.1
ICD-10 Finland
Localized swelling, mass and lump, neck
9.2
6.2
12
14
TPH07
NOMESCO Finland
Cathetrisation of artery
3.7
6.2
26
79
SAA01
NOMESCO Finland
Simple examination of mouth
2.4
6.1
107
749
J44.8
ICD-10 Finland
Other specified chronic obstructive pulmonary disease
3.5
6.0
28
92
TPH04
NOMESCO Finland
Cathetrisation of vein
2.8
6.0
41
176
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(4035726)
80
75
14.23
77.51
1.6
1.2
—
—
—
0
0
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
40
27
16.96
45.95
1.3
1.2
—
—
—
0
0
(3020779) Urea [Moles/volume] in Serum or Plasma
91
199
6.15
42.14
5.3
6.3
mmol/l
6.4
10.9
5.96
86
188
(40768804) Tissue Pathology biopsy report
176
678
4.92
41.13
4.0
1.6
—
—
—
0
0
(3024561) Albumin [Mass/volume] in Serum or Plasma
206
980
4.60
34.38
6.2
3.4
g/l
33.9
35.5
3.57
198
899
(3026389) Candida sp identified in Specimen by Organism specific culture
32
25
14.22
33.68
1.8
1.2
—
—
—
0
0
(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma
37
7
60.07
32.12
5.2
2.4
—
—
—
0
0
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
192
956
3.85
27.94
5.7
3.5
—
—
—
0
0
(3044640) Blood type and Crossmatch panel - Blood
150
642
3.70
27.45
3.9
2.1
—
—
—
0
0
(3007853) Bacteria identified in Skin by Aerobe culture
87
257
4.37
27.18
2.0
1.6
—
—
—
0
0
(3015377) Calcium [Moles/volume] in Serum or Plasma
153
701
3.44
24.46
5.3
2.0
mmol/l
2.4
2.3
0.40
145
567
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
192
1012
3.54
24.38
9.0
4.9
mmol/l
1.2
1.2
2.30
181
892
(3023368) Bacteria identified in Blood by Culture
141
619
3.43
24.09
5.6
3.8
—
—
—
0
0
(3002256) Pathology report gross observation
63
168
4.49
22.18
1.5
1.1
—
—
—
0
0
(3042936) Bacteria identified in Isolate by Culture
94
336
3.63
21.92
2.3
1.9
—
—
—
0
0
(3032080) INR in Blood by Coagulation assay
182
980
3.21
21.28
9.0
8.6
inr
1.1
1.3
4.22
46
256
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
119
505
3.26
20.94
3.5
2.0
—
—
—
0
0
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
197
1119
3.26
20.83
10.0
3.9
umol/l
10.6
12.2
0.75
190
1050
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
194
1103
3.19
20.27
9.4
5.4
mmol/l
1.2
1.2
2.52
162
948
(3018418) pH of Serum or Plasma
131
630
2.93
17.97
4.3
3.3
ph
7.4
7.4
0.85
29
96
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
51
136
4.32
17.77
1.8
1.4
—
—
—
0
0
(3000494) Fungus identified in Specimen by Culture
76
268
3.47
17.75
1.9
1.4
—
—
—
0
0
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
89
347
3.23
17.65
1.9
1.8
—
—
—
0
0
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
68
230
3.54
16.88
2.2
1.9
%
2.2
1.6
1.99
56
197
(3013650) Neutrophils [#/volume] in Blood by Automated count
192
1191
2.73
15.27
12.9
5.9
e9/l
4.6
4.3
1.09
171
1039
(3013826) Glucose [Moles/volume] in Serum or Plasma
210
1393
2.73
14.08
8.9
4.1
mmol/l
6.8
6.8
0.06
205
1290
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
65
246
3.10
13.24
1.9
1.8
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
65
247
3.09
13.14
1.8
1.8
—
—
—
0
0
(40758558) Short blood count panel - Blood
103
501
2.62
13.07
12.2
4.2
—
—
—
0
0
(3003396) Base excess in Arterial blood by calculation
69
273
2.99
12.99
12.7
6.2
mmol/l
2.1
1.4
1.03
62
212
(3000991) Gas panel - Venous blood
54
189
3.27
12.49
11.6
7.1
—
—
—
0
0
(42870588) Differential panel, method unspecified - Blood
129
722
2.39
11.87
7.4
5.3
—
—
—
0
0
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
127
708
2.39
11.77
4.1
2.6
u/l
40.5
33.9
0.53
122
676
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
150
904
2.33
11.56
2.5
2.3
nmol/l
75.7
77.7
0.34
132
782
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
234
1720
2.70
11.39
12.5
5.5
u/l
86.9
75.8
2.55
225
1574
(3001604) Monocytes [#/volume] in Blood
168
1076
2.29
11.04
7.0
5.0
e9/l
0.7
0.6
1.51
145
921
(3006315) Basophils [#/volume] in Blood
168
1082
2.27
10.81
7.1
5.0
e9/l
0.0
0.0
0.01
148
934
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
41
132
3.44
10.78
1.5
1.8
—
—
—
0
0
(3026782) Osmolality of Urine
88
432
2.47
10.66
3.4
2.6
mosm/kgh2o
495.0
562.5
2.13
72
352
(3006504) Eosinophils/100 leukocytes in Blood
158
999
2.24
10.56
7.7
5.3
%
2.7
3.1
1.05
152
915
(3013115) Eosinophils [#/volume] in Blood
171
1118
2.25
10.50
7.3
5.2
e9/l
0.2
0.2
0.12
152
978
(3022096) Basophils/100 leukocytes in Blood
153
969
2.19
10.01
7.8
5.3
%
0.6
0.7
0.68
148
892
(3002030) Lymphocytes/100 leukocytes in Blood
159
1025
2.19
9.92
8.0
5.5
%
22.3
26.8
4.66
151
933
(3019198) Lymphocytes [#/volume] in Blood
167
1100
2.18
9.84
7.1
5.1
e9/l
1.6
1.8
3.97
147
964
(3014576) Chloride [Moles/volume] in Serum or Plasma
65
288
2.61
9.68
10.0
5.6
mmol/l
102.8
104.2
1.09
65
280
(3002582) Erythrocytes [#/volume] in Urine
116
675
2.18
9.23
3.7
2.9
e6/l
183.7
165.9
0.04
87
514
(3018010) Neutrophils/100 leukocytes in Blood
156
1020
2.12
9.14
7.6
5.3
%
61.6
57.7
3.02
150
937
(3030467) Casts [#/volume] in Urine by Automated count
108
619
2.17
8.86
3.3
2.8
e6/l
0.3
0.5
1.25
83
457
(36304419) Bacteria [Presence] in Urine
103
582
2.18
8.74
3.3
2.7
—
—
—
0
0
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
56
242
2.62
8.72
2.9
2.4
umol/l
13.8
8.1
0.49
51
217
(3003694) ABO and Rh group [Type] in Blood
94
515
2.21
8.60
1.4
1.3
—
—
—
0
0
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
45
176
2.83
8.48
3.0
2.1
ml/min/173m2
73.2
61.2
1.52
20
74
(3000850) Epithelial cells [#/volume] in Urine
84
449
2.21
8.11
2.9
2.2
e6/l
3.9
4.8
0.58
71
382
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
97
552
2.12
7.97
2.4
2.0
mg/l
2.8
3.1
0.66
87
460
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
126
791
2.03
7.94
3.9
2.9
—
—
—
0
0
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
22
59
3.95
7.50
1.4
1.4
—
—
—
0
0
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
33
116
3.08
7.49
14.3
8.9
—
—
—
0
0
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
45
191
2.60
7.22
2.9
2.1
u/l
54.8
31.8
0.59
36
162
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
36
138
2.83
7.02
1.6
1.5
—
—
—
0
0
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
19
48
4.16
7.00
1.1
1.3
—
—
—
0
0
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
13
24
5.62
6.83
1.1
1.0
—
—
—
0
0
(40768800) Prostate Pathology biopsy report
11
17
6.68
6.82
1.4
1.2
—
—
—
0
0
(3018095) Leukocytes [#/volume] in Urine
122
792
1.92
6.72
4.7
3.4
e6/l
29.4
103.1
2.31
92
552
(3021589) Normoblasts [#/volume] in Blood
141
963
1.88
6.62
14.9
8.1
e9/l
0.0
0.0
0.48
119
792
(3021960) Folate [Moles/volume] in Serum or Plasma
99
605
1.95
6.48
1.5
1.5
nmol/l
20.9
21.2
0.08
87
505
(3035637) Corticotropin [Mass/volume] in Plasma
11
18
6.31
6.47
1.3
1.4
—
—
—
0
0
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
49
231
2.34
6.26
5.4
2.9
—
—
—
0
0
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
20
58
3.63
6.12
1.6
1.2
—
—
—
0
0
(3019060) Gas panel - Arterial blood
38
161
2.56
6.10
9.6
4.2
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
16
40
4.17
5.98
1.4
1.4
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
16
40
4.17
5.98
1.4
1.4
—
—
—
0
0
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
147
1042
1.81
5.93
2.0
2.0
pmol/l
84.5
94.7
1.92
75
543
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
66
362
2.06
5.79
3.2
2.8
e6/l
1.9
1.6
0.21
37
199
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
74
425
1.99
5.71
5.0
2.0
mmol/l
2.5
2.4
3.04
66
354
(3022948) Iron [Moles/volume] in Serum or Plasma
62
337
2.06
5.56
2.0
2.3
umol/l
11.7
13.3
0.84
57
308
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
16
43
3.88
5.44
1.5
1.2
—
—
—
0
0
(3005895) Myoglobin [Mass/volume] in Serum or Plasma
27
102
2.81
5.41
3.0
2.3
ug/l
811.8
716.2
0.05
27
94
(3017181) Myelocytes/100 leukocytes in Blood
36
158
2.45
5.37
3.4
4.3
%
1.1
0.7
0.51
13
42
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
41
191
2.33
5.37
1.4
1.4
—
—
—
0
0
(3017143) Hepatitis C virus Ab [Presence] in Serum
39
182
2.32
5.09
1.5
1.5
—
—
—
0
0
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
54
288
2.07
5.08
2.0
2.4
%
22.8
24.3
0.23
47
254
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
20
69
3.04
4.70
2.8
2.4
u/ml
0.2
0.3
3.86
12
36
(3012336) Haptoglobin [Mass/volume] in Serum or Plasma
24
92
2.75
4.69
1.4
1.8
g/l
1.8
1.4
0.84
17
82
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
15
43
3.62
4.67
1.5
1.2
—
—
—
0
0
(3030905) Polymorphonuclear cells [#/volume] in Blood
12
30
4.13
4.48
2.6
1.9
e9/l
3.9
5.3
0.91
12
30
(3021879) Hepatitis B virus core Ab [Presence] in Serum
25
101
2.61
4.43
1.6
1.4
—
—
—
0
0
(3001122) Ferritin [Mass/volume] in Serum or Plasma
124
891
1.67
4.40
2.5
2.6
ug/l
233.3
151.3
1.76
114
807
(3021440) Promyelocytes/100 leukocytes in Blood
33
153
2.30
4.37
3.2
4.3
%
0.1
0.1
0.02
12
39
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
12
31
3.99
4.30
2.6
2.7
%
58.3
60.2
0.18
12
31
(3004789) Transferrin [Mass/volume] in Serum or Plasma
54
306
1.93
4.27
2.0
2.3
g/l
2.3
2.3
0.02
46
286
(3025159) Blasts/100 leukocytes in Blood
31
143
2.30
4.16
3.2
4.5
%
0.0
0.0
—
10
32
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
64
387
1.83
4.14
2.5
2.5
e6/l
1.0
1.1
0.12
36
223
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
10
23
4.46
4.12
1.1
1.3
—
—
—
0
0
(3019309) Folate [Moles/volume] in Red Blood Cells
75
481
1.75
3.98
1.9
1.7
nmol/l
1318.5
1138.8
0.93
60
366
(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma
10
24
4.28
3.92
2.5
1.8
u/ml
3.8
156.7
—
10
24
(3002179) Metamyelocytes/100 leukocytes in Blood
30
142
2.24
3.80
3.4
4.4
%
0.7
0.3
—
10
31
(3044889) 12 lead EKG panel
206
1720
1.65
3.77
4.6
4.0
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
47
769
0.54
3.75
2.8
3.2
—
—
—
0
0
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
11
30
3.77
3.67
1.5
1.2
—
—
—
0
0
(3024891) Influenza virus A+B Ag [Presence] in Specimen
14
46
3.14
3.58
1.2
1.1
—
—
—
0
0
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
14
46
3.14
3.58
1.2
1.8
—
—
—
0
0
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
10
26
3.95
3.55
1.5
1.2
—
—
—
0
0
(3020891) Body temperature
22
94
2.45
3.50
10.6
3.9
—
—
—
0
0
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
209
2362
0.61
3.50
4.2
4.9
mmol/l
4.5
4.5
0.34
186
2161
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
207
2342
0.62
3.43
4.1
4.8
mmol/l
1.4
1.4
0.08
182
2135
(46235355) HIV 1 and 2 tests - Meaningful Use set
42
238
1.89
3.31
1.3
1.6
—
—
—
0
0
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
218
2425
0.62
3.13
4.6
5.5
mmol/l
2.5
2.7
1.13
196
2213
(3043409) Potassium [Moles/volume] in Arterial blood
18
74
2.52
3.11
9.4
3.8
mmol/l
4.0
3.9
0.24
18
68
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
10
29
3.53
3.07
1.1
1.2
—
—
—
0
0
(3004451) EKG impression Narrative
6
8
7.62
3.07
1.3
1.4
—
—
—
0
0
(3029937) Albumin [Presence] in Urine by Test strip
81
565
1.60
3.06
4.4
3.7
estimate
0.0
0.0
0.00
27
171
(3028433) Virus identified in Specimen by Culture
5
5
10.14
2.99
1.4
1.0
—
—
—
0
0
(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection
5
5
10.14
2.99
1.2
1.2
—
—
—
0
0
(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection
5
5
10.14
2.99
1.2
1.2
—
—
—
0
0
(3011397) Hemoglobin [Presence] in Urine by Test strip
74
509
1.60
2.95
3.5
3.5
—
—
—
0
0
(3026008) Bacteria identified in Urine by Culture
90
649
1.55
2.93
3.6
2.9
—
—
—
0
0
(3013707) Erythrocyte sedimentation rate by Westergren method
202
1728
1.53
2.90
4.8
4.0
mm/h
18.8
12.1
4.59
189
1567
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
177
1474
1.50
2.88
4.5
3.1
u/l
70.8
48.3
2.06
164
1363
(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection
6
9
6.77
2.88
1.0
1.3
—
—
—
0
0
(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection
6
9
6.77
2.88
1.0
1.3
—
—
—
0
0
(3024354) Oxygen [Partial pressure] in Venous blood
35
196
1.89
2.87
3.5
2.7
kpa
4.2
4.3
0.07
35
188
(3023520) Reticulocytes [#/volume] in Blood
36
204
1.87
2.85
2.3
2.7
e9/l
68.7
67.7
0.06
25
163
(40768795) Lymph node Pathology biopsy report
5
6
8.45
2.76
1.6
1.0
—
—
—
0
0
(3010503) CD19 cells [#/volume] in Blood
5
6
8.45
2.76
3.4
1.5
e9/l
0.0
0.1
—
5
6
(3018405) Lactate [Moles/volume] in Arterial blood
20
92
2.26
2.74
8.6
3.4
mmol/l
1.1
1.3
0.79
20
87
(3025941) Bacteria identified in Stool by Culture
21
99
2.21
2.72
1.4
1.2
—
—
—
0
0
(3045788) Cell count panel - Pleural fluid
8
19
4.30
2.69
1.1
1.3
—
—
—
0
0
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
71
494
1.57
2.68
4.2
3.9
ng/l
444.7
405.9
0.05
63
413
(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma
7
15
4.75
2.61
2.3
1.3
ug/l
13.4
15.6
—
7
15
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
8
20
4.08
2.58
1.9
1.1
—
—
—
0
0
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
96
721
1.49
2.54
3.9
2.2
u/l
52.7
57.1
0.57
90
667
(40761536) Microorganisms panel - Urine sediment
30
167
1.89
2.52
4.8
3.1
—
—
—
0
0
(44790047)
8
21
3.88
2.48
1.5
1.1
—
—
—
0
0
(44790049)
8
21
3.88
2.48
1.5
1.1
—
—
—
0
0
(44806118)
8
21
3.88
2.48
1.5
1.1
—
—
—
0
0
(44790048)
8
21
3.88
2.48
1.5
1.1
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
14
58
2.48
2.40
1.6
1.2
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
14
58
2.48
2.40
1.6
1.2
—
—
—
0
0
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
5
8
6.33
2.38
1.2
1.9
—
—
—
0
0
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
6
13
4.69
2.28
1.0
1.2
—
—
—
0
0
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
7
18
3.96
2.26
2.0
1.1
—
—
—
0
0
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
10
36
2.84
2.22
1.1
1.2
—
—
—
0
0
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
9
30
3.06
2.16
1.1
1.2
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
138
1139
1.40
2.12
2.4
2.5
—
—
—
0
0
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
250
2295
1.56
2.11
32.6
12.7
mg/l
35.7
23.9
6.57
241
1771
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
5
10
5.06
2.08
2.2
2.1
—
—
—
0
0
(21494755) Public health laboratory ask at order entry panel
5
146
0.33
2.07
1.0
1.5
—
—
—
0
0
(3008757) Leukocyte morphology finding [Identifier] in Blood
7
20
3.56
2.06
4.6
3.3
—
—
—
0
0
(21494434) Karyotype in Bone marrow
7
20
3.56
2.06
1.0
1.2
—
—
—
0
0
(3000492) Spirometry study
33
202
1.71
2.06
1.5
1.3
—
—
—
0
0
(3021447) Carbon dioxide [Partial pressure] in Venous blood
37
235
1.66
2.02
4.0
3.5
kpa
6.1
5.8
0.80
37
228
(3042111) Morphology [Interpretation] in Bone marrow Narrative
9
32
2.87
2.01
1.0
2.2
—
—
—
0
0
(3048821) Cortisol [Moles/volume] in Serum or Plasma --post 1 mg dexamethasone PO overnight
9
32
2.87
2.01
1.9
1.3
—
—
—
0
0
(3002032) Base excess in Venous blood by calculation
37
237
1.64
1.96
4.0
3.4
mmol/l
3.3
2.2
1.19
31
190
(3012501) Base excess in Blood by calculation
11
45
2.50
1.95
4.8
3.1
mmol/l
2.9
3.3
0.21
11
26
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
8
27
3.02
1.95
1.1
1.3
—
—
—
0
0
(3022806) Fractional oxyhemoglobin in Capillary blood
8
27
3.02
1.95
3.1
1.6
%
88.6
90.0
—
8
27
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
17
85
2.06
1.94
1.8
1.6
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
13
58
2.30
1.93
1.6
1.2
—
—
—
0
0
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
16
79
2.08
1.89
1.4
1.5
—
—
—
0
0
(40768806) Pleura Pathology biopsy report
7
22
3.23
1.89
1.4
1.2
—
—
—
0
0
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
48
671
0.66
1.88
1.7
1.7
mmol/l
1.2
1.4
0.94
37
557
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
8
28
2.91
1.87
1.0
1.1
—
—
—
0
0
(3042631) Mycobacterium sp identified in Specimen
8
28
2.91
1.87
1.8
3.1
—
—
—
0
0
(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood
22
123
1.85
1.85
3.7
2.4
%
1.6
1.3
0.83
22
123
(3045142) Bone marrow Pathology biopsy report
6
17
3.58
1.84
1.0
1.1
—
—
—
0
0
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
6
17
3.58
1.84
1.2
1.3
—
—
—
0
0
(40760892) CBC W Ordered Manual Differential panel - Blood
59
428
1.47
1.82
5.6
4.1
—
—
—
0
0
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
64
477
1.44
1.72
1.9
1.7
mg/l
1.7
1.2
0.65
54
372
(3021601) Nitrite [Presence] in Urine by Test strip
129
1083
1.34
1.68
5.4
4.9
estimate
0.0
0.0
0.00
30
177
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
8
31
2.62
1.67
1.1
1.4
—
—
—
0
0
(3012441) Differential panel - Pleural fluid
7
25
2.84
1.66
1.0
1.2
—
—
—
0
0
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
11
49
2.29
1.65
1.4
1.5
—
—
—
0
0
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
11
49
2.29
1.65
1.4
1.2
—
—
—
0
0
(3005719) IgG [Mass/volume] in Serum or Plasma
26
159
1.70
1.65
4.5
2.2
g/l
9.8
11.3
0.81
26
145
(3047181) Lactate [Moles/volume] in Blood
14
70
2.05
1.62
14.2
6.2
mmol/l
0.8
1.3
6.33
14
65
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
8
32
2.54
1.61
1.4
1.1
—
—
—
0
0
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
38
259
1.54
1.58
2.9
2.6
ug/l
7.5
7.9
0.06
33
221
(3035350) Ketones [Presence] in Urine by Test strip
128
1082
1.32
1.56
4.3
3.5
estimate
0.0
0.0
0.00
27
178
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
8
33
2.46
1.55
1.1
1.4
—
—
—
0
0
(3009261) Glucose [Presence] in Urine by Test strip
130
1103
1.32
1.54
4.3
3.5
estimate
0.0
0.0
0.00
30
171
(3024928) Oxygen saturation in Venous blood
12
58
2.11
1.51
1.2
2.6
—
—
—
0
0
(3016650) Hepatitis A virus Ab [Presence] in Serum
9
37
2.48
1.49
1.0
1.1
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
15
80
1.92
1.47
1.5
1.3
—
—
—
0
0
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
15
80
1.92
1.47
3.4
3.5
—
—
—
0
0
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
76
942
0.74
1.46
4.7
3.7
%
18.4
24.2
2.16
36
438
(3015736) pH of Urine
104
862
1.32
1.44
3.8
3.3
—
—
—
0
0
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
210
2267
0.75
1.43
3.8
4.3
mmol/l
1.3
1.3
0.09
187
2049
(3019230) Fractional oxyhemoglobin in Venous blood
10
47
2.17
1.35
1.2
2.1
%
51.5
60.7
—
10
47
(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose
0
39
0.00
1.34
0.0
1.3
—
7.5
—
0
25
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
6
24
2.53
1.31
2.7
3.4
—
—
—
0
0
(40759836) Histone Ab [Presence] in Serum by Immunoblot
6
24
2.53
1.31
1.2
1.2
—
—
—
0
0
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
6
24
2.53
1.31
1.2
1.2
—
—
—
0
0
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
6
24
2.53
1.31
1.2
1.2
—
—
—
0
0
(3026179) Normetanephrine [Moles/volume] in Serum or Plasma
8
34
2.39
1.30
1.1
1.4
nmol/l
0.6
0.5
—
8
29
(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence
10
48
2.12
1.29
1.0
1.4
—
—
—
0
0
(3037756) Immunofixation for Serum or Plasma
8
35
2.32
1.28
1.0
1.4
—
—
—
0
0
(3037467) Urinalysis macro (dipstick) panel - Urine
177
1592
1.28
1.26
5.1
3.9
—
—
—
0
0
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
6
25
2.43
1.25
1.2
1.2
—
—
—
0
0
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
6
25
2.43
1.25
1.2
1.2
—
—
—
0
0
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
6
25
2.43
1.25
1.2
1.2
—
—
—
0
0
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
5
19
2.66
1.22
1.0
1.1
—
—
—
0
0
(3026493) Urate [Moles/volume] in Serum or Plasma
79
645
1.31
1.20
2.8
2.5
umol/l
336.5
7777.5
2.75
71
554
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
188
1709
1.27
1.20
4.8
3.5
pmol/l
14.9
15.0
0.17
174
1516
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
102
1184
0.79
1.14
4.8
3.8
ug/l
5.7
2.0
0.77
84
1056
(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence
15
88
1.74
1.13
1.5
1.7
—
132.0
—
0
5
(3029080) Hemoglobin [Entitic mass] in Reticulocytes
7
30
2.36
1.13
2.1
2.7
pg
34.9
33.6
—
7
30
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
18
112
1.65
1.11
1.1
1.2
iu/ml
162.2
103.9
—
5
38
(3051611) Lipemic interference index of Serum or Plasma
5
21
2.40
1.09
8.4
2.1
—
—
—
0
0
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
7
32
2.22
1.09
1.3
1.3
—
—
—
0
0
(3044941) Cell count panel - Synovial fluid
7
32
2.22
1.09
1.4
1.6
—
—
—
0
0
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
7
32
2.22
1.09
1.3
1.4
—
—
—
0
0
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
24
342
0.68
1.04
4.4
5.1
%
33.5
32.0
0.24
14
221
(3024522) Salmonella sp identified in Specimen by Organism specific culture
5
22
2.29
1.04
1.2
1.1
—
—
—
0
0
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
5
22
2.29
1.04
1.2
1.1
—
—
—
0
0
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
5
22
2.29
1.04
1.2
1.1
—
—
—
0
0
(3025468) Yersinia sp identified in Specimen by Organism specific culture
5
22
2.29
1.04
1.2
1.1
—
—
—
0
0
(3005988) Vibrio sp identified in Specimen by Organism specific culture
5
22
2.29
1.04
1.2
1.1
—
—
—
0
0
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
5
22
2.29
1.04
1.2
1.1
—
—
—
0
0
(3011288) Drugs identified in Urine by Screen method
5
22
2.29
1.04
1.2
1.3
—
—
—
0
0
(3022145) Colonoscopy Study observation
31
225
1.42
0.99
1.4
1.3
—
—
—
0
0
(3023419) Bacteria identified in Sputum by Culture
7
36
1.97
0.97
1.6
3.1
—
—
—
0
0
(1616796) Gas panel - Central venous blood
8
42
1.93
0.89
3.6
2.8
—
—
—
0
0
(3048929) Epstein Barr virus Ab [Presence] in Serum
8
43
1.88
0.88
1.1
1.1
—
—
—
0
0
(3045424) Erythrocytes [Presence] in Urine
6
30
2.02
0.87
1.2
1.6
—
—
—
0
0
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
8
44
1.84
0.86
1.1
1.2
—
—
—
0
0
(3037522) Nuclear Ab [Titer] in Serum
37
285
1.34
0.85
1.6
1.4
titre
740.0
572.7
—
8
79
(3019225) pH of Specimen
31
232
1.38
0.85
5.0
3.1
—
—
—
0
0
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
6
31
1.95
0.85
1.2
1.1
—
—
—
0
0
(40760888) Immunoglobulin light chains.free panel - Serum
8
46
1.76
0.83
1.3
1.2
—
—
—
0
0
(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma
8
46
1.76
0.83
1.4
1.2
u/l
11.7
16.3
—
8
41
(4010399)
26
190
1.40
0.82
1.3
1.4
—
—
—
0
0
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
64
536
1.25
0.80
1.7
1.7
pmol/l
519.1
12925593.8
0.50
48
441
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
55
660
0.80
0.79
3.6
2.6
ug/l
0.6
0.8
0.65
45
440
(4146454)
0
27
0.00
0.78
0.0
3.4
—
—
—
0
0
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
217
2278
0.82
0.74
5.4
6.6
mmol/mol
39.9
40.6
0.40
198
2102
(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum
7
38
1.86
0.74
1.3
1.4
—
386.9
—
0
12
(3045414) Leukocytes [Presence] in Urine
12
76
1.60
0.73
1.6
1.7
—
—
—
0
0
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
7
40
1.77
0.71
1.1
1.6
—
—
—
0
0
(3020682) Albumin/Creatinine [Ratio] in Urine
78
893
0.83
0.71
3.3
4.0
mg/mmol
10.6
7.3
0.47
48
552
(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum
9
143
0.62
0.71
1.3
1.3
—
50.4
—
0
10
(40768797) Stomach Pathology biopsy report
39
312
1.29
0.71
1.4
1.2
—
—
—
0
0
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
91
802
1.19
0.69
2.9
3.1
ng/l
1845.8
1505.6
0.31
84
679
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
227
2367
0.83
0.68
4.2
4.9
mmol/l
6.0
6.1
0.21
209
2126
(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma
5
28
1.80
0.66
1.0
1.1
g/l
1.7
1.5
—
5
22
(36660697) Celiac disease serology panel - Serum
10
154
0.64
0.66
1.1
1.1
—
—
—
0
0
(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
5
30
1.68
0.61
1.2
1.1
u/ml
308.6
203.0
—
5
16
(4268621)
0
20
0.00
0.60
0.0
2.2
—
—
—
0
0
(3052851) Hemolysis interference index of Serum or Plasma
10
64
1.58
0.59
8.4
3.4
—
—
—
0
0
(3051014) Leukocytes [#/area] in Urine sediment by Automated count
0
23
0.00
0.58
0.0
2.4
—
0.6
—
0
7
(3009542) Hematocrit [Volume Fraction] of Blood
218
2082
1.18
0.58
31.7
13.8
%
36.7
40.1
7.48
133
1382
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
8
122
0.65
0.56
1.1
1.3
—
—
—
0
0
(40761535) Cells panel - Urine sediment
24
187
1.31
0.55
3.6
2.8
—
—
—
0
0
(40761511) CBC panel - Blood by Automated count
250
2421
1.21
0.53
28.5
12.1
—
—
—
0
0
(3013139) Helicobacter pylori Ag [Presence] in Stool
10
146
0.67
0.53
1.3
1.2
—
—
—
0
0
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
6
39
1.55
0.53
1.2
1.3
—
—
—
0
0
(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum
10
66
1.53
0.53
1.1
1.1
—
—
—
0
0
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
222
2131
1.17
0.52
5.6
4.4
mu/l
2.4
2.5
0.09
201
1910
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
39
329
1.21
0.48
13.7
6.5
—
—
—
0
0
(3019150) Specific gravity of Urine by Refractometry
57
499
1.18
0.48
5.0
3.7
kg/l
1.0
1.0
—
8
81
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
20
253
0.78
0.47
1.5
1.6
—
—
—
0
0
(3037121) Protein [Mass/volume] in Urine
12
86
1.41
0.45
3.6
2.0
g/l
0.3
0.2
—
7
26
(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma
13
95
1.39
0.44
1.2
2.4
u/l
39.4
39.3
0.01
13
84
(3012516) Albumin [Mass/volume] in Urine
76
838
0.87
0.43
2.6
3.2
mg/l
838.1
288.8
0.32
51
530
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
6
91
0.65
0.43
1.2
1.6
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
6
91
0.65
0.43
1.0
1.0
—
—
—
0
0
(1001926) Buprenorphine [Presence] in Urine by Screen method
5
32
1.57
0.42
1.2
1.2
—
—
—
0
0
(40766048) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum by Immunoassay
0
16
0.00
0.41
0.0
1.1
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
7
105
0.66
0.40
1.1
1.8
—
—
—
0
0
(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum
0
19
0.00
0.39
0.0
1.3
—
0.4
—
0
13
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
228
2210
1.14
0.38
28.9
11.7
ml/min/173m2
84.5
76.4
7.24
203
1776
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
34
394
0.85
0.37
1.3
1.3
iu/ml
26.2
40.7
0.84
13
127
(3014051) Protein [Presence] in Urine by Test strip
6
42
1.44
0.35
2.0
1.8
—
—
—
0
0
(3021788) Differential panel - Synovial fluid
6
45
1.34
0.34
2.2
1.5
—
—
—
0
0
(3049717) Cytology report of Urine Cyto stain
11
83
1.34
0.32
3.5
1.8
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
90
840
1.10
0.30
5.0
3.7
—
—
—
0
0
(3009508) Creatinine [Moles/volume] in Urine
80
858
0.91
0.28
2.6
3.1
mmol/l
6.8
7.9
1.30
69
713
(3016921) Smith extractable nuclear Ab [Units/volume] in Serum
8
64
1.26
0.27
1.6
1.2
—
3.2
—
0
11
(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum
8
67
1.20
0.26
1.6
1.1
—
12.4
—
0
11
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
5
73
0.68
0.26
1.4
1.6
—
—
—
0
0
(3017732) Neutrophils [#/volume] in Blood
13
158
0.81
0.24
2.9
2.9
e9/l
4.5
4.0
—
8
105
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
107
1017
1.08
0.24
5.2
3.8
ng/l
63.4
46.6
0.35
90
744
(3016879) Cocaine [Presence] in Urine
5
40
1.25
0.22
1.4
1.2
—
—
—
0
0
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
5
40
1.25
0.22
1.0
1.1
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
5
41
1.22
0.22
1.4
1.2
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
5
42
1.19
0.21
1.4
1.2
—
—
—
0
0
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
5
42
1.19
0.21
1.4
2.5
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
5
42
1.19
0.21
1.4
1.2
—
—
—
0
0
(3007821) Glucose [Moles/volume] in Serum or Plasma --baseline
0
11
0.00
0.21
0.0
1.1
—
8.1
—
0
11
(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma
0
11
0.00
0.21
0.0
1.5
—
—
—
0
0
(44806420)
0
11
0.00
0.21
0.0
2.2
—
—
—
0
0
(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]
0
11
0.00
0.21
0.0
1.5
—
—
—
0
0
(3023430) Cat dander IgE Ab [Units/volume] in Serum
0
10
0.00
0.21
0.0
1.1
—
8.1
—
0
5
(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot
0
10
0.00
0.21
0.0
1.2
—
—
—
0
0
(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot
0
10
0.00
0.21
0.0
1.2
—
—
—
0
0
(42529582) MDA5 Ab [Presence] in Serum by Line blot
0
10
0.00
0.21
0.0
1.2
—
—
—
0
0
(3013637) Mi-2 Ab [Presence] in Serum
0
10
0.00
0.21
0.0
1.2
—
—
—
0
0
(3019897) Erythrocyte distribution width [Ratio] by Automated count
0
10
0.00
0.21
0.0
3.9
—
14.1
—
0
10
(3015183) Erythrocyte sedimentation rate
0
10
0.00
0.21
0.0
1.3
—
—
—
0
0
(3025018) Bordetella pertussis Ab [Titer] in Serum
0
10
0.00
0.21
0.0
1.5
—
—
—
0
0
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
0
10
0.00
0.21
0.0
1.8
—
—
—
0
0
(3006462) Nitrate [Presence] in Urine
0
10
0.00
0.21
0.0
1.9
—
—
—
0
0
(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright
0
12
0.00
0.21
0.0
1.2
—
246.6
—
0
7
(3027944) Amphetamines [Presence] in Urine
5
43
1.17
0.21
1.4
1.2
—
—
—
0
0
(3021901) Oxygen saturation in Capillary blood
5
43
1.17
0.21
1.0
2.3
—
—
—
0
0
(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection
0
13
0.00
0.21
0.0
1.0
—
—
—
0
0
(3025130) Human papilloma virus identified in Specimen
0
13
0.00
0.21
0.0
1.9
—
—
—
0
0
(3014133) Dog dander IgE Ab [Units/volume] in Serum
0
13
0.00
0.21
0.0
1.1
—
1.7
—
0
5
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
0
13
0.00
0.21
0.0
1.2
—
—
—
0
0
(3048402) Erythrocytes [#/area] in Urine sediment by Automated count
0
13
0.00
0.21
0.0
1.8
—
2.1
—
0
7
(44813793)
0
14
0.00
0.20
0.0
1.0
—
—
—
0
0
(44816559) Phosphatidylethanol [Mass/volume] in Blood
6
49
1.23
0.20
2.0
1.2
—
—
—
0
0
(3022621) pH of Urine by Test strip
17
147
1.17
0.18
2.2
2.6
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
17
195
0.86
0.18
1.3
1.4
—
—
—
0
0
(3004588) Protein electrophoresis panel - Serum or Plasma
18
161
1.13
0.13
1.1
1.3
—
—
—
0
0
(3000330) Specific gravity of Urine by Test strip
11
127
0.86
0.12
4.4
3.9
—
—
—
0
0
(3007164) IgA [Mass/volume] in Serum or Plasma
38
405
0.93
0.12
1.6
1.3
g/l
3.2
2.8
0.58
26
237
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
10
86
1.17
0.11
1.8
1.9
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
30
280
1.08
0.11
1.3
1.3
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
56
585
0.95
0.10
5.0
3.3
—
—
—
0
0
(3028026) IgM [Mass/volume] in Serum or Plasma
15
135
1.12
0.10
2.1
1.3
g/l
1.6
1.1
0.37
15
123
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
35
370
0.94
0.09
1.1
1.3
u/ml
5.0
11.4
0.63
15
135
(3044290) Cell count panel - Cerebral spinal fluid
5
48
1.04
0.09
1.2
1.1
—
—
—
0
0
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
43
450
0.95
0.08
1.4
1.2
u/ml
1.6
1.7
0.04
19
116
(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
6
57
1.05
0.08
1.2
1.2
—
—
—
0
0
(3010813) Leukocytes [#/volume] in Blood
256
2579
0.95
0.08
44.1
18.6
e9/l
7.5
6.7
3.65
250
2482
(3026361) Erythrocytes [#/volume] in Blood
256
2579
0.95
0.08
44.1
18.5
e12/l
4.1
4.5
32.11
251
2483
(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation
5
63
0.79
0.08
1.4
1.9
pmol/l
231.4
231.2
—
5
57
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
7
67
1.05
0.08
1.3
1.4
—
—
—
0
0
(3007461) Platelets [#/volume] in Blood
256
2577
0.95
0.07
44.1
18.5
e9/l
263.2
241.2
4.47
251
2493
(40768443) Skin Pathology biopsy report
9
85
1.06
0.07
1.2
1.3
—
—
—
0
0
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
11
99
1.12
0.06
1.1
1.3
—
—
—
0
0
(3005322) IgE [Units/volume] in Serum or Plasma
14
130
1.08
0.04
1.2
1.3
u/ml
256.7
232.6
0.10
14
116
(3022313) Gas panel - Capillary blood
14
132
1.06
0.02
3.2
3.7
—
—
—
0
0
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
249
2493
0.99
0.00
16.4
9.0
u/l
26.1
26.5
0.14
242
2383
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
13
125
1.04
0.00
2.5
2.3
—
—
—
0
0
(3013512) EKG study
77
766
1.01
0.00
4.5
4.1
—
—
—
0
0
(3051101) Glucose [Moles/volume] in Cord blood
0
7
0.00
0.00
0.0
7.0
—
—
—
0
0
(3028371) Actinomyces sp identified in Specimen by Organism specific culture
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(3027300) Silver Birch IgE Ab [Units/volume] in Serum
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3005033) Fetal Nuchal fold Thickness US
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(3016244) Insulin [Units/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
3.9
—
20.6
—
0
7
(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis
0
5
0.00
0.00
0.0
2.2
—
7.2
—
0
5
(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
2.0
—
—
—
0
0
(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(3020951) Lymphocytes/100 leukocytes in Cerebral spinal fluid
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3001186) Copper [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.0
—
18.5
—
0
5
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(3035933) Granulocytes/100 leukocytes in Blood
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3039602) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Capillary blood
0
5
0.00
0.00
0.0
2.4
—
1.3
—
0
5
(3015479) Mycobacterium sp identified in Blood by Organism specific culture
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3047352) Trisomy 18 risk [Likelihood] in Fetus
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(21491868) Cryoglobulin [Mass/volume] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3008116) Ketones [Moles/volume] in Urine by Test strip
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(4133840)
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood
0
6
0.00
0.00
0.0
4.2
—
—
—
0
0
(3016628) Fibrinogen Ag [Mass/volume] in Platelet poor plasma by Immunoassay
0
6
0.00
0.00
0.0
1.3
—
0.5
—
0
6
(3036669) Protein S actual/normal in Platelet poor plasma by Coagulation assay
0
6
0.00
0.00
0.0
1.0
—
108.2
—
0
6
(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative
0
6
0.00
0.00
0.0
2.2
—
—
—
0
0
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
5
57
0.88
0.00
3.4
1.4
—
—
—
0
0
(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood
0
6
0.00
0.00
0.0
4.2
—
—
—
0
0
(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum
0
9
0.00
0.00
0.0
1.0
—
10.1
—
0
9
(3019832) Treponema pallidum Ab [Presence] in Serum
8
87
0.92
0.00
1.0
1.6
—
—
—
0
0
(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum
0
9
0.00
0.00
0.0
1.0
—
1516.9
—
0
9
(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay
0
6
0.00
0.00
0.0
1.3
—
24.8
—
0
6
(3003327) Ova and parasites identified in Stool by Light microscopy
5
58
0.86
0.00
1.4
1.6
—
—
—
0
0
(3034426) Prothrombin time (PT)
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate
0
6
0.00
0.00
0.0
6.8
—
—
—
0
0
(1761482) Bacteria [#/volume] in Urine by Culture
7
79
0.88
0.00
3.1
4.5
—
—
—
0
0
(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(3043238) Trisomy 21 risk [Likelihood] in Fetus
0
9
0.00
0.00
0.0
1.7
—
—
—
0
0
(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
4.0
—
—
—
0
0
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: C3_FLOOROFMOUTH_EXALLC – Malignant neoplasm of floor of mouth, excluding all cancers (controls excluding all cancers)
GWS hits: -
This endpoint is excluded from FinRegistry analyses (omitted endpoint).